You are here

Cytex Therapeutics, Inc.

Company Information
Address
2608 Erwin Road Suite 19A
Durham, NC 27705-4597
United States


http://www.cytextherapeutics.com

Information

UEI: G9RMDCWJYGL3

# of Employees: 4


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Addressing bone marrow lesions that compromise osteochondral tissue repair

    Amount: $282,265.00

    ABSTRACT Degenerative joint diseases such as osteoarthritis (OA) remain the source of significant pain and disability, affecting over 30 million adults with an annual US economic burden of more than $ ...

    STTRPhase I2023Department of Health and Human Services National Institutes of Health
  2. Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model

    Amount: $799,998.00

    Abstract Osteoarthritis (OA) is a leading cause of disability in the developed world, affecting over 30 million adults in the US with an economic burden of over $486 billion per year. Advanced OA is m ...

    SBIRPhase II2022Department of Health and Human Services National Institutes of Health
  3. A Treatment Paradigm for Femoracetabular Impingement (FAI)

    Amount: $1,679,032.00

    Abstract: Fewer than 1 in 5 young patients suffering from activity limiting hip osteoarthritis (OA) choose to undergo total hip replacement (THR) surgery, opting instead for symptom management. Despit ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  4. Cartilage Regeneration with Tunable Inflammation Resistance

    Amount: $4,773,722.00

    Abstract: Femoroacetabular impingement or FAI is a commonly diagnosed condition affecting a younger patient population than the general osteoarthritis (OA) population. Untreated, FAI invariably leads ...

    SBIRPhase II2020Department of Health and Human Services National Institutes of Health
  5. Regenerative rotator cuff repair in a clinically relevant chronic disease model

    Amount: $225,000.00

    ABSTRACT Rotator cuff repairRCRis a common first line surgical solution to symptomatic rotator cuff injurywith overRCRs performed annuallyand growing at a rate ofUnfortunatelyof the cases are complica ...

    STTRPhase I2019Department of Health and Human Services National Institutes of Health
  6. Evaluating the Safety and Efficacy of Cartilage Regeneration with Tunable Inflammation Resistance

    Amount: $225,000.00

    Abstract The repair of large cartilage lesionswhich often lead to osteoarthritisOAremains a significant clinical problem with few good treatment optionsPrevious work at Cytex has focused on the develo ...

    SBIRPhase I2018Department of Health and Human Services National Institutes of Health
  7. Unicondylar Resurfacing in an Ovine Osteoarthritis Disease Model

    Amount: $1,406,959.00

    AbstractThe treatment of large cartilage lesions is a difficult clinical problem for which there are few good solutionsLeft untreatedthese lesions tend to degenerate to chronic pain and osteoarthritis ...

    STTRPhase II2017Department of Health and Human Services National Institutes of Health
  8. A D osteoarthritis model targeting patient populations with high risk genetic polymorphisms

    Amount: $225,000.00

    Abstract Osteoarthritis OA is a degenerative joint disease that affects an estimated million adults in the United States and results in an economic burden of over $ billion per year Although ...

    SBIRPhase I2017Department of Health and Human Services National Institutes of Health
  9. A crosslinked cartilage-derived matrix for cartilage tissue engineering

    Amount: $1,199,997.00

    Abstract OsteoarthritisOAremains a significant source of significant pain and disabilityaffecting overmillion adults with an economic burden of over $billion per year to the USJoint replacement is a w ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
  10. Functional Tissue Engineering for Cartilage Repair

    Amount: $1,159,905.00

    Abstract It is estimated that only aboutof young patients suffering from!activity limiting hip osteoarthritisOAchoose to undergo traditional hip replacement surgeryThis low percentage is attributed to ...

    SBIRPhase II2017Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government